Pre-order Enquiry
Request Free Sample
Global Metabolic Disorder Therapeutics Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14038990 | Publishing Date : 01-Apr-2019 | No. of pages : 105
Detailed TOC of Global Metabolic Disorder Therapeutics Market Size, Status and Forecast 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metabolic Disorder Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Lysosomal Storage Diseases
1.4.3 Diabetes
1.4.4 Obesity
1.4.5 Inherited Metabolic Disorders
1.4.6 Hypercholesterolemia
1.5 Market by Application
1.5.1 Global Metabolic Disorder Therapeutics Market Share by Application (2014-2025)
1.5.2 Oral
1.5.3 Parenteral
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Metabolic Disorder Therapeutics Market Size
2.2 Metabolic Disorder Therapeutics Growth Trends by Regions
2.2.1 Metabolic Disorder Therapeutics Market Size by Regions (2014-2025)
2.2.2 Metabolic Disorder Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Metabolic Disorder Therapeutics Market Size by Manufacturers
3.1.1 Global Metabolic Disorder Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Metabolic Disorder Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Metabolic Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Metabolic Disorder Therapeutics Key Players Head office and Area Served
3.3 Key Players Metabolic Disorder Therapeutics Product/Solution/Service
3.4 Date of Enter into Metabolic Disorder Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Metabolic Disorder Therapeutics Market Size by Type (2014-2019)
4.2 Global Metabolic Disorder Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Metabolic Disorder Therapeutics Market Size (2014-2019)
5.2 Metabolic Disorder Therapeutics Key Players in United States
5.3 United States Metabolic Disorder Therapeutics Market Size by Type
5.4 United States Metabolic Disorder Therapeutics Market Size by Application
6 Europe
6.1 Europe Metabolic Disorder Therapeutics Market Size (2014-2019)
6.2 Metabolic Disorder Therapeutics Key Players in Europe
6.3 Europe Metabolic Disorder Therapeutics Market Size by Type
6.4 Europe Metabolic Disorder Therapeutics Market Size by Application
7 China
7.1 China Metabolic Disorder Therapeutics Market Size (2014-2019)
7.2 Metabolic Disorder Therapeutics Key Players in China
7.3 China Metabolic Disorder Therapeutics Market Size by Type
7.4 China Metabolic Disorder Therapeutics Market Size by Application
8 Japan
8.1 Japan Metabolic Disorder Therapeutics Market Size (2014-2019)
8.2 Metabolic Disorder Therapeutics Key Players in Japan
8.3 Japan Metabolic Disorder Therapeutics Market Size by Type
8.4 Japan Metabolic Disorder Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Metabolic Disorder Therapeutics Market Size (2014-2019)
9.2 Metabolic Disorder Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Metabolic Disorder Therapeutics Market Size by Type
9.4 Southeast Asia Metabolic Disorder Therapeutics Market Size by Application
10 India
10.1 India Metabolic Disorder Therapeutics Market Size (2014-2019)
10.2 Metabolic Disorder Therapeutics Key Players in India
10.3 India Metabolic Disorder Therapeutics Market Size by Type
10.4 India Metabolic Disorder Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Metabolic Disorder Therapeutics Market Size (2014-2019)
11.2 Metabolic Disorder Therapeutics Key Players in Central & South America
11.3 Central & South America Metabolic Disorder Therapeutics Market Size by Type
11.4 Central & South America Metabolic Disorder Therapeutics Market Size by Application
12 International Players Profiles
12.1 Novo Nordisk A/S
12.1.1 Novo Nordisk A/S Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metabolic Disorder Therapeutics Introduction
12.1.4 Novo Nordisk A/S Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
12.1.5 Novo Nordisk A/S Recent Development
12.2 Sanofi S.A.
12.2.1 Sanofi S.A. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metabolic Disorder Therapeutics Introduction
12.2.4 Sanofi S.A. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
12.2.5 Sanofi S.A. Recent Development
12.3 Boehringer Ingelheim GmbH
12.3.1 Boehringer Ingelheim GmbH Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metabolic Disorder Therapeutics Introduction
12.3.4 Boehringer Ingelheim GmbH Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
12.3.5 Boehringer Ingelheim GmbH Recent Development
12.4 Eli Lilly and Company
12.4.1 Eli Lilly and Company Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metabolic Disorder Therapeutics Introduction
12.4.4 Eli Lilly and Company Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
12.4.5 Eli Lilly and Company Recent Development
12.5 Merck KgaA
12.5.1 Merck KgaA Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metabolic Disorder Therapeutics Introduction
12.5.4 Merck KgaA Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
12.5.5 Merck KgaA Recent Development
12.6 Amgen, Inc.
12.6.1 Amgen, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Metabolic Disorder Therapeutics Introduction
12.6.4 Amgen, Inc. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
12.6.5 Amgen, Inc. Recent Development
12.7 AstraZeneca PLC
12.7.1 AstraZeneca PLC Company Details
12.7.2 Company Description and Business Overview
12.7.3 Metabolic Disorder Therapeutics Introduction
12.7.4 AstraZeneca PLC Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
12.7.5 AstraZeneca PLC Recent Development
12.8 Actelion Pharmaceuticals Ltd.
12.8.1 Actelion Pharmaceuticals Ltd. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Metabolic Disorder Therapeutics Introduction
12.8.4 Actelion Pharmaceuticals Ltd. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
12.8.5 Actelion Pharmaceuticals Ltd. Recent Development
12.9 Shire PLC
12.9.1 Shire PLC Company Details
12.9.2 Company Description and Business Overview
12.9.3 Metabolic Disorder Therapeutics Introduction
12.9.4 Shire PLC Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
12.9.5 Shire PLC Recent Development
12.10 AbbVie, Inc.
12.10.1 AbbVie, Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Metabolic Disorder Therapeutics Introduction
12.10.4 AbbVie, Inc. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
12.10.5 AbbVie, Inc. Recent Development
12.11 Biocon Ltd.
12.12 BioMarin Pharmaceutical, Inc.
12.13 Bristol-Myers Squibb Company
12.14 Cipla, Inc.
12.15 CymaBay Therapeutics, Inc.
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Metabolic Disorder Therapeutics Market Size, Status and Forecast 2019-2025
List of Tables and FiguresTable Metabolic Disorder Therapeutics Key Market Segments
Table Key Players Metabolic Disorder Therapeutics Covered
Table Global Metabolic Disorder Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Metabolic Disorder Therapeutics Market Size Market Share by Type 2014-2025
Figure Lysosomal Storage Diseases Figures
Table Key Players of Lysosomal Storage Diseases
Figure Diabetes Figures
Table Key Players of Diabetes
Figure Obesity Figures
Table Key Players of Obesity
Figure Inherited Metabolic Disorders Figures
Table Key Players of Inherited Metabolic Disorders
Figure Hypercholesterolemia Figures
Table Key Players of Hypercholesterolemia
Table Global Metabolic Disorder Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Oral Case Studies
Figure Parenteral Case Studies
Figure Others Case Studies
Figure Metabolic Disorder Therapeutics Report Years Considered
Table Global Metabolic Disorder Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Metabolic Disorder Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Metabolic Disorder Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Metabolic Disorder Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Metabolic Disorder Therapeutics Market Share by Regions 2014-2019
Figure Global Metabolic Disorder Therapeutics Market Share by Regions 2014-2019
Figure Global Metabolic Disorder Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Metabolic Disorder Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Metabolic Disorder Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Metabolic Disorder Therapeutics Market Share by Manufacturers in 2018
Table Global Metabolic Disorder Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Metabolic Disorder Therapeutics Product/Solution/Service
Table Date of Enter into Metabolic Disorder Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Metabolic Disorder Therapeutics Market Size Share by Type (2014-2019)
Figure Global Metabolic Disorder Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Metabolic Disorder Therapeutics Market Size Share by Application (2014-2019)
Figure Global Metabolic Disorder Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Metabolic Disorder Therapeutics Revenue Market Share by Application in 2018
Figure United States Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Metabolic Disorder Therapeutics Market Share (2018-2019)
Table United States Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Metabolic Disorder Therapeutics Market Share by Type (2014-2019)
Table United States Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Metabolic Disorder Therapeutics Market Share by Application (2014-2019)
Figure Europe Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Metabolic Disorder Therapeutics Market Share (2018-2019)
Table Europe Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Metabolic Disorder Therapeutics Market Share by Type (2014-2019)
Table Europe Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Metabolic Disorder Therapeutics Market Share by Application (2014-2019)
Figure China Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Metabolic Disorder Therapeutics Market Share (2018-2019)
Table China Metabolic Disorder Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Metabolic Disorder Therapeutics Market Share by Type (2014-2019)
Table China Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Metabolic Disorder Therapeutics Market Share by Application (2014-2019)
Figure Japan Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Metabolic Disorder Therapeutics Market Share (2018-2019)
Table Japan Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Metabolic Disorder Therapeutics Market Share by Type (2014-2019)
Table Japan Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Metabolic Disorder Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Metabolic Disorder Therapeutics Market Share (2018-2019)
Table Southeast Asia Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Metabolic Disorder Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Metabolic Disorder Therapeutics Market Share by Application (2014-2019)
Figure India Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Metabolic Disorder Therapeutics Market Share (2018-2019)
Table India Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Metabolic Disorder Therapeutics Market Share by Type (2014-2019)
Table India Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Metabolic Disorder Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Metabolic Disorder Therapeutics Market Share (2018-2019)
Table Central & South America Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Metabolic Disorder Therapeutics Market Share by Type (2014-2019)
Table Central & South America Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Metabolic Disorder Therapeutics Market Share by Application (2014-2019)
Table Novo Nordisk A/S Company Details
Table Novo Nordisk A/S Revenue in Metabolic Disorder Therapeutics Business (2014-2019) (Million US$)
Figure Novo Nordisk A/S Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019)
Table Novo Nordisk A/S Recent Development
Table Sanofi S.A. Company Details
Table Sanofi S.A. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi S.A. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019)
Table Sanofi S.A. Recent Development
Table Boehringer Ingelheim GmbH Company Details
Table Boehringer Ingelheim GmbH Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim GmbH Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019)
Table Boehringer Ingelheim GmbH Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Merck KgaA Company Details
Table Merck KgaA Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Merck KgaA Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019)
Table Merck KgaA Recent Development
Table Amgen, Inc. Company Details
Table Amgen, Inc. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Amgen, Inc. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019)
Table Amgen, Inc. Recent Development
Table AstraZeneca PLC Company Details
Table AstraZeneca PLC Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca PLC Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019)
Table AstraZeneca PLC Recent Development
Table Actelion Pharmaceuticals Ltd. Company Details
Table Actelion Pharmaceuticals Ltd. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Actelion Pharmaceuticals Ltd. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019)
Table Actelion Pharmaceuticals Ltd. Recent Development
Table Shire PLC Company Details
Table Shire PLC Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Shire PLC Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019)
Table Shire PLC Recent Development
Table AbbVie, Inc. Company Details
Table AbbVie, Inc. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$)
Figure AbbVie, Inc. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019)
Table AbbVie, Inc. Recent Development
Table Biocon Ltd. Company Details
Table BioMarin Pharmaceutical, Inc. Company Details
Table Bristol-Myers Squibb Company Company Details
Table Cipla, Inc. Company Details
Table CymaBay Therapeutics, Inc. Company Details
Table Global Metabolic Disorder Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Metabolic Disorder Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Metabolic Disorder Therapeutics Market Size Share by Regions in 2025
Figure United States Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Metabolic Disorder Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Metabolic Disorder Therapeutics Market Size by Product (2019-2025)
Figure Global Metabolic Disorder Therapeutics Market Size by Product in 2025
Table Global Metabolic Disorder Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Metabolic Disorder Therapeutics Market Size by Application (2019-2025)
Figure Global Metabolic Disorder Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Metabolic Disorder Therapeutics Market Size, Status and Forecast 2019-2025
Novo Nordisk A/SSanofi S.A.
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck KgaA
Amgen, Inc.
AstraZeneca PLC
Actelion Pharmaceuticals Ltd.
Shire PLC
AbbVie, Inc.
Biocon Ltd.
BioMarin Pharmaceutical, Inc.
Bristol-Myers Squibb Company
Cipla, Inc.
CymaBay Therapeutics, Inc.
Request Sample
Request Discount
